BioCentury
ARTICLE | Clinical News

AclarusDx: Pilot trial completed enrollment

July 23, 2012 7:00 AM UTC

Exonhit completed enrollment of 160 newly referred patients with memory impairment in a U.S. pilot trial evaluating AclarusDx. The product has CE Mark approval and is available in France. ...